Esteban Lopez Sells 250 Shares of Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation (NASDAQ:ADUS) Director Esteban Lopez sold 250 shares of the business’s stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $93.00, for a total value of $23,250.00. Following the sale, the director directly owned 3,450 shares in the company, valued at $320,850. The trade was a 6.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Addus HomeCare Trading Down 0.5%

NASDAQ ADUS traded down $0.50 during trading hours on Thursday, hitting $93.26. 158,172 shares of the company were exchanged, compared to its average volume of 247,104. The stock has a 50-day moving average price of $96.10 and a 200 day moving average price of $105.73. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.08. Addus HomeCare Corporation has a 52 week low of $89.76 and a 52 week high of $124.43. The stock has a market cap of $1.74 billion, a PE ratio of 17.24, a price-to-earnings-growth ratio of 1.27 and a beta of 0.92.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.52 by $0.10. The company had revenue of $363.50 million for the quarter, compared to analysts’ expectations of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The firm’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.42 earnings per share. Analysts forecast that Addus HomeCare Corporation will post 6.24 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of ADUS. Royal Bank of Canada grew its stake in Addus HomeCare by 24.3% in the first quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock worth $682,000 after purchasing an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Addus HomeCare by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after purchasing an additional 459 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Addus HomeCare by 6.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after purchasing an additional 2,952 shares in the last quarter. Jane Street Group LLC grew its stake in Addus HomeCare by 387.6% in the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after purchasing an additional 8,780 shares in the last quarter. Finally, Intech Investment Management LLC grew its stake in Addus HomeCare by 44.7% in the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock worth $1,420,000 after purchasing an additional 4,439 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.

Analysts Set New Price Targets

ADUS has been the topic of a number of analyst reports. KeyCorp reaffirmed an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday, February 25th. Stephens cut their target price on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 25th. Barclays cut their target price on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a research note on Friday, May 15th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. Finally, Citizens Jmp reaffirmed a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a research note on Monday. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Addus HomeCare has an average rating of “Moderate Buy” and an average price target of $131.22.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.